ArticleCancers2021

Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors.

Thorsten Derlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.